Just now, 2024JCR was officially released! Reply to "2024JCR" in the
background to get the full list (Note: 2024IF was released in 2025)
CA-A CANCER JOURNAL FOR CLINICIANS's IF was cut in half, but it still
ranked first with its high score of 232.4. The second is two Nature review
sub-issues.
In terms of domestic journals, Signal Transduction and Targeted Therapy
ranked first with a high score of 52.7.
Nature and Science are 48.5 and 45.8 respectively.
For more journals, please check the table below.


































